Menu -- Part 10: Retinal Reports from the 2007 AAO Meeting
Posted Sep 26 2008 5:17pm
During the 2007 American Academy of Ophthalmology (AAO) Meeting, and the Subspecialty Days preceding it, especially Retina 2007, I received briefs about the meetings from both Ophthalmology Times and Ocular Surgery News. Using these briefs, I was able to prepare comprehensive writeups of both the two-day Retina 2007 presentations and retinal highlights from the opening day of the main meeting. These writeups were presented in a series of three reports:
● New Developments in posterior segment drug delivery – a discussion of potetial solid implants, such as Retisert and Vitrasert from Bausch & Lomb, and a subretinal implant system from SurModics called I-vation.
And, finally, an interview with Dr. Judah Folkman, the father of anti-angiogenic agents, and the keynote speaker for the opening session of the AAO Meeting.
● More from Retina 2007 - A Comparison of Lucentis vs. Avastin; - An Update on the CATT Study; - Additional information about the Ellex 2RT laser treatment.
● Retinal-related Information from the Main AAO Meeting - The keynote address by Dr. Judah Folkman; - An overview of intravitreal drugs for treating diabetic retinopathy; and, - Intravitreal therapy for vein-occlusive disease.